Device Trial Radar · NCT00705913
Randomized Sizing and Hemodynamic Study Mitroflow vs. Magna
Last checked: Nov 20, 2026Latest source record: Jan 9, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
368
Actual
Start
Jun 2008
Primary completion
Sep 2011
Study completion Sep 2011
Sponsor
- Lead sponsor
- Sorin Group USA, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 27, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare sizing,implant techniques, and hemodynamics between the Mitroflow Pericardial Aortic Valve and the Edwards Magna Heart Valve.
Conditions
- Aortic Valve Disease
Interventions
Mitroflow Aortic Pericardial Heart Valve (CarboMedics)Device
Study to compare sizing, implant techniques and hemodynamics of the Mitroflow Pericardial valve as compared to the Edwards Magna valve
Carpentier-Edwards Magna Tissue ValveDevice
Study to compare sizing, implant techniques and hemodynamics of the Mitroflow Valve as compared to the Edwards Magna valve
Primary outcomes
What the sponsor says the trial is designed to measure.
- Determine which of the two valve types, the Mitroflow or Magna valve, will demonstrate lower pressure gradients relative to aortic annulusTime frame: 6 months
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
Sharp Memorial Hospital
San Diego, California
Pepin Heart Hospital
Tampa, Florida
St. Luke's Medical Center
Kansas City, Kansas
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.